PMC:7408073 / 63262-63367 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T397","span":{"begin":64,"end":69},"obj":"Body_part"}],"attributes":[{"id":"A397","pred":"fma_id","subj":"T397","obj":"http://purl.org/sig/ont/fma/fma9670"}],"text":"CaNa2EDTA was approved by FDA in chelation therapy for lowering blood lead levels a long time ago (1953)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T133","span":{"begin":64,"end":69},"obj":"Body_part"}],"attributes":[{"id":"A133","pred":"uberon_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"CaNa2EDTA was approved by FDA in chelation therapy for lowering blood lead levels a long time ago (1953)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2278","span":{"begin":0,"end":9},"obj":"Chemical"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"CaNa2EDTA was approved by FDA in chelation therapy for lowering blood lead levels a long time ago (1953)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T794","span":{"begin":64,"end":69},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T795","span":{"begin":64,"end":69},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T796","span":{"begin":82,"end":83},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"CaNa2EDTA was approved by FDA in chelation therapy for lowering blood lead levels a long time ago (1953)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T303","span":{"begin":0,"end":105},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"CaNa2EDTA was approved by FDA in chelation therapy for lowering blood lead levels a long time ago (1953)."}